Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2009-06-05
2011-12-06
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S401000, C548S331500
Reexamination Certificate
active
08071636
ABSTRACT:
Described herein are compounds for and methods of treating conditions or diseases in a subject by administering to the subject a pharmaceutical composition containing an effective amount of an α-adrenergic modulator. The compounds and methods are also useful for alleviating types of pain, both acute and chronic.
REFERENCES:
patent: 4256755 (1981-03-01), Smith, Jr.
patent: 2003/0022926 (2003-01-01), Lavand'Homme
patent: 1174988 (1969-12-01), None
patent: WO 2003/099289 (2003-12-01), None
patent: WO 2006/127426 (2006-11-01), None
Kostic et. al., Annals of Neurology, 1997, American Neurological Association, vol. 41, pp. 497-504.
Mann et. al., Journal of Neurology, Neurosurgery, and Psychiatry, 1987, vol. 50, pp. 341-344.
Tomas et. al., Current Medicinal Chemistry, 2006, Bentham Science Pub., vol. 13, No. 16, pp. 1859-1876.
Zarkovic, Molecular Aspects of Medicine, 2003, Pergamon, vol. 24, pp. 293-303.
“Prodrugs and Drug Delivery Systems,” which is a chapter in Richard B. Silverman, Organic Chemistry of Drug Design and Drug Action, 2d Ed., Elsevier Academic Press: Amsterdam, 2004, pp. 496-557.
David J. Hart et al (J. Org. Chem. 48: 289-294 (1983).
Messier et al., 1995, Pharmacol. Toxicol. 76, pp. 308-311.
Kim and Chung 1992, Pain 150, pp. 355-363.
Dixon, W.J., Ann. Rev. Pharmacol. Toxicol. 20:441-462 (1980).
Chow Ken
Donello John E.
Fang Wenkui K.
Garst Michael E.
Gil Daniel W.
Allergan Inc.
Ene Doina G.
Forrestal Kevin J.
Padmanabhan Sreeni
Pihonak Sarah
LandOfFree
Methods of treating alpha adrenergic mediated conditions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating alpha adrenergic mediated conditions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating alpha adrenergic mediated conditions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4301308